The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

By 2030, What Market Size Is The Mental Health Clinical Trials Market Expected To Reach Based On Its 2026 Value?

The market for mental health clinical trials has experienced robust expansion in recent years. This market is projected to expand from $3.23 billion in 2025 to $3.52 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.9%. Historically, this growth was driven by several factors, including the rising incidence of mental health disorders, the broadening of pharmaceutical research and development pipelines, heightened public awareness concerning mental health conditions, an increase in funding for clinical research, and a greater adoption of standardized diagnostic criteria.

The mental health clinical trials market is poised for significant expansion in the foreseeable future. It is projected to reach $4.89 billion by 2030, with a compound annual growth rate (CAGR) of 8.6%. This anticipated growth during the forecast period stems from factors such as the greater acceptance of digital mental health interventions, an uptick in investments in personalized psychiatry research, the broadening of global mental health trial networks, enhanced regulatory backing for novel trial designs, and the expanded application of data-driven outcome assessment. Noteworthy trends within this period involve the rising adoption of decentralized clinical trial models, increased deployment of digital therapeutics in trials, the growing integration of AI-based tools for patient recruitment, the expansion of remote patient monitoring in studies, and a sharpened focus on the generation of real-world evidence.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27343&type=smp

What Key Factors Are Affecting The Mental Health Clinical Trials Market Demand?

The escalating incidence of mental health disorders is projected to stimulate the expansion of the mental health clinical trials market moving forward. Mental health disorders are defined as conditions that considerably impact an individual’s emotions, thought processes, conduct, and overall psychological health. The increase in these disorders is attributed to heightened stress from modern lifestyles, encompassing work pressures, social isolation, and constant digital connectivity. Mental health clinical trials are crucial for improving care by assessing the safety and efficacy of new medications, therapeutic approaches, and behavioral interventions for mental health conditions. For example, in May 2024, the American Psychiatric Association, a US-based non-profit organization, reported that around 43% of adults in the USA were experiencing increased anxiety in 2024, up from 37% in 2023 and 32% in 2022. Thus, the growing prevalence of mental health disorders is a significant catalyst for the growth of the mental health clinical trials market.

How Are Different Segments Classified In The Mental Health Clinical Trials Market Segment Analysis?

The mental health clinical trials market covered in this report is segmented –

1) By Phase: Phase I, Phase II, Phase III, Phase IV

2) By Study Design: Interventional, Observational, Other Study Designs

3) By Disorder: Anxiety Disorders, Depression, Bipolar Affective Disorder, Dissociation And Dissociative Disorders, Schizophrenia, Other Disorders

4) By Sponsor: Pharmaceutical And Biopharmaceutical Companies, Government Agencies, Other Sponsors

Subsegments:

1) By Phase I: Single Ascending Dose, Multiple Ascending Dose, First In Human, Pharmacokinetics Studies

2) By Phase II: Dose Ranging Studies, Proof Of Concept Studies, Randomized Controlled Trials, Open Label Studies

3) By Phase III: Large Scale Randomized Trials, Multicenter Studies, Comparative Effectiveness Trials, Double Blind Studies

4) By Phase IV: Post Marketing Surveillance, Long Term Safety Studies, Real World Evidence Studies, Pharmacovigilance Studies

What Trends Are Influencing Changes In The Mental Health Clinical Trials Market?

Key players in the mental-health clinical trials market are increasingly concentrating on developing innovative solutions, such as software-enhanced drug therapies, to boost treatment efficacy, personalize patient care, and improve real-world therapeutic outcomes. Software-enhanced drug therapies are treatments that combine traditional medications with clinically validated therapeutic software, helping to improve patient outcomes by tailoring care, enhancing adherence, and offering real-time behavioral or symptom-management support. As an example, in October 2024, Click Therapeutics Inc., a US-based digital therapeutics company, launched Click SE, a new product aimed at pioneering software-enhanced drug therapies that blend prescription software with pharmacotherapy to deliver added clinical benefit and enable novel endpoints in mental-health clinical development. Click SE is a software-centric product family, consisting of regulated mobile and cloud applications built on Click’s AI-enabled DTx platform. It functions by delivering structured therapeutic programs, real-time symptom monitoring, and medication-specific digital support designed to complement a co-prescribed drug. Its unique features include adaptive algorithms that customize content to patient response, integration pathways for pharmacologic dosing schedules, and built-in metrics for objective trial endpoints; its applications cover augmentation of antipsychotics for negative symptoms, adjunctive therapy in depression, and support in substance-use disorders.

Who Are The Companies Driving Activity In The Mental Health Clinical Trials Market?

Major companies operating in the mental health clinical trials market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., AbbVie Inc., Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, GSK plc, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., IQVIA Holdings Inc., Biogen Inc., ICON plc., Parexel International Corporation, CMIC Holdings Co. Ltd., Medpace Holdings Inc., PSI CRO AG., Supernus Pharmaceuticals Inc., Worldwide Clinical Trials, Inc., Ergomed, Celerion Inc., Biotrial S.A.S., Lindus Health Ltd., Novotech Health Holdings Pte Ltd., Precision for Medicine Inc.

Get The Full Mental Health Clinical Trials Market Report:

https://www.thebusinessresearchcompany.com/report/mental-health-clinical-trials-global-market-report

Which Region Dominates The Mental Health Clinical Trials Market By Market Share?

North America was the largest region in the mental health clinical trials market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mental health clinical trials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Mental Health Clinical Trials Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/mental-health-clinical-trials-global-market-report

Browse Through More Reports Similar to the Global Mental Health Clinical Trials Market 2026, By The Business Research Company

Elevator And Escalator Market Report 2026

https://www.thebusinessresearchcompany.com/report/elevator-and-escalator-global-market-report

Smart Elevators Market Report

https://www.thebusinessresearchcompany.com/report/smart-elevators-global-market-report

Iot In Elevators Market Report

https://www.thebusinessresearchcompany.com/report/iot-in-elevators-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.